Tissue-based epigenetic alterations of RASSF1, GSTP1, and APC urine-based testing of PCA3 or TMPRSS2-ERG together with PCA3 have been proposed for improved PCa diagnostics. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.